1. 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Issue 5 (15th April 2020) Authors: Du, Chenxing; Mao, Xuehan; Xu, Yan; Yan, Yuting; Yuan, Chenglu; Du, Xin; Liu, Jiahui; Fan, Huishou; Wang, Qi; Sui, Weiwei; Deng, Shuhui; Fu, Mingwei; Li, Zengjun; Li, Chengwen; Zhao, Jiawei; Yi, Shuhua; Liu, Lanting; Hao, Mu; Zou, Dehui; Zhao, Yaozhong Journal: Leukemia & lymphoma Issue: Volume 61:Issue 5(2020) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Issue 7 (July 2015) Authors: Li, Fei; Hao, Mu; Feng, Xiaoyan; Zang, Meirong; Qin, Yu; Yi, Shuhua; Li, Zengjun; Xu, Yan; Zhou, Lili; Sui, Weiwei; Deng, Shuhui; Zou, Dehui; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients. (9th June 2020) Authors: Mao, Xue‐Han; Zhuang, Jun‐Ling; Zhao, Duo‐Duo; Li, Xiao‐Qing; Du, Xin; Hao, Mu; Xu, Yan; Yan, Yu‐Ting; Liu, Jia‐Hui; Fan, Hui‐Shou; Sui, Wei‐Wei; Deng, Shu‐Hui; Li, Cheng‐Wen; Zhao, Jia‐Wei; Yi, Shu‐Hua; Du, Chen‐Xing; Zou, De‐Hui; Li, Zeng‐Jun; Zhao, Yao‐Zhong; Zhan, Feng‐Huang Journal: European journal of haematology Issue: Volume 105:Number 3(2020) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low serum miR‐19a expression as a novel poor prognostic indicator in multiple myeloma. Issue 8 (19th September 2014) Authors: Hao, Mu; Zang, Meirong; Wendlandt, Erik; Xu, Yan; An, Gang; Gong, Dasen; Li, Fei; Qi, Fang; Zhang, Yanru; Yang, Ye; Zhan, Fenghuang; Qiu, Lugui Journal: International journal of cancer Issue: Volume 136:Issue 8(2015:Apr. 15) Page Start: 1835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment. Issue 1 (15th January 2023) Authors: Wei, Xiaojing; Yu, Zhen; Tang, Peixia; Sun, Hao; Gong, Lixin; Liu, Lanting; Fang, Teng; He, Yi; Wang, Tingyu; Sui, Weiwei; Xu, Yan; An, Gang; Xu, Zhenshu; Ma, Xiaoke; Qiu, Lugui; Hao, Mu Journal: Clinical and translational medicine Issue: Volume 13:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data. Issue 11 (November 2013) Authors: An, Gang; Shi, Lihui; Xu, Yan; Zou, Dehui; Deng, Shuhui; Sui, Weiwei; Zhu, Guoqing; Xie, Zhenqing; Hao, Mu; Sun, Qi; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria. Issue 12 (15th October 2022) Authors: Yan, Wenqiang; Fan, Huishou; Xu, Jingyu; Liu, Jiahui; Li, Lingna; Du, Chenxing; Deng, Shuhui; Sui, Weiwei; Hao, Mu; Yi, Shuhua; Zou, Dehui; Qiu, Lugui; Xu, Yan; An, Gang Journal: Leukemia & lymphoma Issue: Volume 63:Issue 12(2022) Page Start: 2955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗